Laboratory for Cardio-Immunology

Led by Kai-Uwe Jarr, M.D.

Pro-efferocytic nanoparticles are specifically taken up by lesional macrophages and prevent atherosclerosis


Journal article


Alyssa M. Flores, Niloufar Hosseini-Nassab, K. Jarr, Jianqin Ye, Xingjun Zhu, R. Wirka, A. Koh, P. Tsantilas, Ying Wang, V. Nanda, Y. Kojima, Yitian Zeng, Mozhgan Lotfi, R. Sinclair, I. Weissman, E. Ingelsson, B. Smith, N. Leeper
Nature Nanotechnology, 2020

Semantic Scholar DOI PubMedCentral PubMed
Cite

Cite

APA   Click to copy
Flores, A. M., Hosseini-Nassab, N., Jarr, K., Ye, J., Zhu, X., Wirka, R., … Leeper, N. (2020). Pro-efferocytic nanoparticles are specifically taken up by lesional macrophages and prevent atherosclerosis. Nature Nanotechnology.


Chicago/Turabian   Click to copy
Flores, Alyssa M., Niloufar Hosseini-Nassab, K. Jarr, Jianqin Ye, Xingjun Zhu, R. Wirka, A. Koh, et al. “Pro-Efferocytic Nanoparticles Are Specifically Taken up by Lesional Macrophages and Prevent Atherosclerosis.” Nature Nanotechnology (2020).


MLA   Click to copy
Flores, Alyssa M., et al. “Pro-Efferocytic Nanoparticles Are Specifically Taken up by Lesional Macrophages and Prevent Atherosclerosis.” Nature Nanotechnology, 2020.


BibTeX   Click to copy

@article{alyssa2020a,
  title = {Pro-efferocytic nanoparticles are specifically taken up by lesional macrophages and prevent atherosclerosis},
  year = {2020},
  journal = {Nature Nanotechnology},
  author = {Flores, Alyssa M. and Hosseini-Nassab, Niloufar and Jarr, K. and Ye, Jianqin and Zhu, Xingjun and Wirka, R. and Koh, A. and Tsantilas, P. and Wang, Ying and Nanda, V. and Kojima, Y. and Zeng, Yitian and Lotfi, Mozhgan and Sinclair, R. and Weissman, I. and Ingelsson, E. and Smith, B. and Leeper, N.}
}